Multilocus sequence typing of urogenital chlamydia trachomatis from patients with different degrees of clinical symptoms

Sexually Transmitted Diseases

Volumn 38, Issue 6, 2011, Pages 490-494

  Christerson, Linus ^a   De Vries, Henry J C ^b,c,d   Klint, Markus ^a   Herrmann, Björn ^a   Morré, Servaas A ^e  

^a UPPSALA UNIVERSITY   (Sweden)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c Infectious Disease Cluster   (Netherlands)

^d NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^e VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL PAIN; ARTICLE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; CHLAMYDIA TRACHOMATIS; CHLAMYDIAL URETHRITIS; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE COURSE; FEMALE; GENOTYPE; HUMAN; HUMAN CELL; MULTILOCUS SEQUENCE TYPING; NUCLEOTIDE SEQUENCE; QUESTIONNAIRE;

BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL PROTEINS; BACTERIAL TYPING TECHNIQUES; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; FEMALE; FEMALE UROGENITAL DISEASES; GENOTYPE; HELA CELLS; HUMANS; MULTILOCUS SEQUENCE TYPING; NETHERLANDS; PHYLOGENY; SEQUENCE ANALYSIS, DNA;

EID: 79957650212     PISSN: 01485717     EISSN: 15374521     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e31820b8be0     Document Type: Article

References (18)

1. World Health Organization. Global prevalence and incidence of selected curable sexually transmitted infections: Overview and estimates. Geneva, Switzerland: World Health Organization, 2001.
2. Hafner LM, McNeilly C. Vaccines for Chlamydia infections of the female genital tract. Future Microbiol 2008; 3:67-77. (Pubitemid 351385952)
3. Stephens RS. The cellular paradigm of chlamydial pathogenesis. Trends Microbiol 2003; 11:44-51. (Pubitemid 36084355)
4. Brunham RC, Peeling RW. Chlamydia trachomatis antigens: Role in immunity and pathogenesis. Infect Agents Dis 1994; 3:218-233. (Pubitemid 24367058)
5. Brunham RC, Rekart ML. Considerations on Chlamydia trachomatis disease expression. FEMS Immunol Med Microbiol 2009; 55:162-166.
6. Darville T, Hiltke TJ. Pathogenesis of genital tract disease due to Chlamydia trachomatis. J Infect Dis 2010; 201:114-125.
7. Pedersen LN, Herrmann B, Moller JK. Typing Chlamydia trachomatis: From egg yolk to nanotechnology. FEMS Immunol Med Microbiol 2009; 55:120-130.
8. Klint M, Fuxelius HH, Goldkuhl RR, et al. High-resolution genotyping of Chlamydia trachomatis strains by multilocus sequence analysis. J Clin Microbiol 2007; 45:1410-1414. (Pubitemid 46762391)
9. Grieshaber NA, Sager JB, Dooley CA, et al. Regulation of the Chlamydia trachomatis histone h1-like protein hc2 is ispE dependent and ihtA independent. J Bacteriol 2006; 188:5289-5292. (Pubitemid 44051496)
10. Lysen M, Osterlund A, Rubin CJ, et al. Characterization of ompA genotypes by sequence analysis of DNA from all detected cases of Chlamydia trachomatis infections during 1 year of contact tracing in a Swedish county. J Clin Microbiol 2004; 42:1641-1647. (Pubitemid 38500810)
11. Jurstrand M, Christerson L, Klint M, et al. Characterization of Chlamydia trachomatis by ompA sequencing and multilocus sequence typing (MLST) in a Swedish county before and after identification of the new variant. Sex Transm Infect 2010; 86:56-60.
12. Pannekoek Y, Morelli G, Kusecek B, et al. Multi locus sequence typing of Chlamydiales: Clonal groupings within the obligate intracellular bacteria Chlamydia trachomatis. BMC Microbiol 2008; 8:42.
13. Dean D, Bruno WJ, Wan R, et al. Predicting phenotype and emerging strains among Chlamydia trachomatis infections. Emerg Infect Dis 2009; 15:1385-1394.
14. Herrmann B, Torner A, Low N, et al. Emergence and spread of Chlamydia trachomatis variant, Sweden. Emerg Infect Dis 2008; 14:1462-1465.
15. Brunelle BW, Sensabaugh GF. The ompA gene in Chlamydia trachomatis differs in phylogeny and rate of evolution from other regions of the genome. Infect Immun 2006; 74:578-585. (Pubitemid 43023113)
16. Bailey RL, Natividad-Sancho A, Fowler A, et al. Host genetic contribution to the cellular immune response to Chlamydia trachomatis: Heritability estimate from a gambian twin study. Drugs Today (Barc) 2009; 45(suppl B):45-50.
17. Morre SA, Karimi O, Ouburg S. Chlamydia trachomatis: Identification of susceptibility markers for ocular and sexually transmitted infection by immunogenetics. FEMS Immunol Med Microbiol 2009; 55:140-153.
18. Morre SA, Ouburg S, Pena AS, et al. The EU FP6 epigenchlamydia consortium: Contribution of molecular epidemiology and host-pathogen genomics to understanding Chlamydia trachomatis-related disease. Drugs Today (Barc) 2009; 45(suppl B):7-13.